Ocata Therapeutics Inc fka OCAT

[Jmasdoc]

I suspect the suprise results they got were more cells actually implanted then they expected with the low dose they started with in these patients. For them it would be a very positive result but for us it doesn't help the stock price short term if there wasn't some vision improvement. I am hoping like all of you that there was some vision improvement. If there was, there won't be a short term bump and then a retreat. The stock will bump then continue to rise. Even though it is 3 or so years before they might get revenue, people will jump all over it knowing the potential revenue this company can have of 10's of billions of dollars. Yes it will take more studies but if you can show vision improvement in your first cohort of patients, that is ground breaking medical technology.